Detection and characterization of tumor hypoxia using pO2 histography

Antioxidants and Redox Signaling

Volumn 9, Issue 8, 2007, Pages 1221-1235

  Vaupel, Peter ^a   Höckel, Michael ^b   Mayer, Arnulf ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ANEMIA; BREAST CANCER; DEMOGRAPHY; DIFFUSION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPOXIA; NECK CANCER; OXYGEN TENSION; OXYGEN TRANSPORT; PERFUSION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOLID TUMOR; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

ANOXIA; BREAST NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS; OXIMETRY; OXYGEN; PROGNOSIS; SOFTWARE; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 34447506424     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1628     Document Type: Review

References (150)

1. Adam MF, Gabalski EC, Bloch DA, Oehlert JW, Brown JM, Elsaid AA, Pinto HA, and Terris DJ. Tissue oxygen distribution in head and neck cancer patients. Head Neck 21: 146-153, 1999.
2. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I, and West C. Glucose transporter Glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7: 928-934, 2001.
3. Aquino-Parsons C, Green A, and Minchinton AI. Oxygen tension in primary gynaecological tumours: The influence of carbon dioxide concentration. Radiother Oncol 57: 45-51, 2000.
4. Aquino-Parsons C, Luo C, Vikse CM, and Olive PL. Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia. Radiother Oncol 51: 179-185, 1999.
5. Becker A, Hänsgen G, Bloching M, Weigel C, Lautenschläger C, and Dunst J. Oxygenation of squamous cell carcinoma of the head and neck: Comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 42: 35-41, 1998.
6. Becker A, Hänsgen G, Richter C, and Dunst J. Oxygenierungsstatus von Plattenepithelkarzinomen der Kopf-Hals-Region. Strahlenther Onkol 174: 484-486, 1998.
7. Becker A, Stadler P, Lavey RS, Hänsgen G, Kuhnt T, Lautenschläger C, Feldmann HJ, Molls M, and Dunst J. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46: 459-466, 2000.
8. 18F- fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67: 339-344, 2003.
9. Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K, and Ogawa A. Change of oxygen pressure in glioblastoma tissue under various conditions. J Neuro-Oncol 58: 47-52, 2002.
10. Brizel DM. Human tumor oxygenation: The Duke University Medical Center Experience. In: Tumor Hypoxia, edited by Vaupel P and Kelleher DK. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999, pp. 29-38.
11. Brizel DM, Dodge RK, Clough RW, and Dewhirst MW. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53: 113-117, 1999.
12. Brizel DM, Rosner GL, Harrelson J, Prosnitz LR, and Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 30: 635-642, 1994.
13. Brizel DM, Rosner GL, Prosnitz LR, and Dewhirst MW. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases. Int J Radiat Oncol Biol Phys 32: 1121-1125, 1995.
14. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, and Dewhirst MW. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943, 1996.
15. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Dodge RK, Charles HC, Samulski TV, Prosnitz LR, and Dewhirst MW. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 56: 5347-5350, 1996.
16. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, and Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-289, 1997.
17. Clavo B, Robaina F, Catalá L, Pérez JL, Camarés MA, Morera J, López L, Suárez G, Macías D, Rivero J, and Hernández MA. Effect of cervical spinal cord stimulation on regional blood flow and oxygenation in advanced head and neck tumours. Ann Oncol 15: 802-807, 2004.
18. Clavo B, Robaina F, Morera J, Ruiz-Egea E, Pérez JL, Macías D, Caramés MA, Catalá L, Hernández MA, and Günderoth M. Increase of brain tumor oxygenation during cervical spinal cord stimulation. J Neurosurg 96: 94-100, 2002.
19. Collingridge DR, Piepmeier JM, Rockwell S, and Knisely JP. Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53: 127-131, 1999.
20. Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, and West CML. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 57: 53-59, 2000.
21. Cooper RA, West CM, Logue JP, Davidson SE, Miller A, Roberts S, Stafford IJ, Honess DJ, and Hunter RD. Changes in oxygenation during radiotherapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 45: 119-126, 1999.
22. 2 distribution in human malignant brain tumours. Adv Exp Med Biol 345: 465-470, 1994.
23. Cvetkovic D, Movsas B, Dicker AP, Hanlon AL, Greenberg RE, Chapman JD, Hanks GE, and Tricoli JV. Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. Urology 57: 821-825, 2001.
24. 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy. Int J Radiat Oncol Biol Phys 61: 480-491, 2005.
25. Di Martino EFN, Gagel B, and Schramm O. Evaluation of tumor oxygenation by color duplex sonography: A new approach. Otolaryngol Head Neck Surg 132: 765-769, 2005.
26. Dietz A, Rudat V, Conradt C, Vanselow B, Wollensack P, Staar S, Eckel H, Volling P, Schröder M, Wannenmacher M, Müller RP, and Weidenauer H. Prognostischer Stellenwert des Hämoglobinwertes vor primärer Radiochemotherapie von Kopf-Hals-Karzinomen. HNO 48: 655-664, 2000.
27. Dietz A, Vanselow B, Rudat V, Conradt C, Weidauer H, Kallinowski F, and Dollner R. Prognostic impact of reoxygenation in advanced cancer of the head and neck during initial course of chemoradiation or radiotherapy alone. Head Neck 25: 50-58, 2003.
28. Doll CM, Milosevic M, Pintilie M, Hill RP, and Fyles AW. Estimating hypoxic status in human tumors: A simulation using Eppendorf oxygen probe data in cervical cancer patients. Int J Radiat Oncol Biol Phys 55: 1239-1246, 2003.
29. Dunst J, Hänsgen G, Lautenschläger C, Fuchsel G, and Becker A. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon. Int J Radiat Oncol Biol Phys 43: 367-373, 1999.
30. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H, and Hänsgen G. Anemia in cervical cancers: Impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56: 778-787, 2003.
31. Dunst J, Stadler P, Becker A, Lautenschläger C, Pelz T, Hänsgen G, Molls M, and Kuhnt T. Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther Onkol 179: 521-526, 2003.
32. Eble MJ, Lohr F, and Wannenmacher M. Oxygen tension distribution in head and neck carcinomas after peroral oxygen therapy. Onkologie 18: 136-140, 1995.
33. Evans SM and Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Letters 195: 1-16, 2003.
34. Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, and Koch CJ. Hypoxia in human intraperitoneal and extremity sarcomas. Int J Radiat Oncol Biol Phys 49: 587-596, 2001.
35. Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang W-T, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, and Koch CJ. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10: 8177-8184, 2004.
36. Evans SM, Judy KD, Dunphy I, Jenkins WT, Nelson PT, Collins R, Wileyto EP, Jenkins K, Hahn SM, Stevens CW, Judkins AR, Phillips P, Geoerger B, and Koch CJ. Comparative measurements of hypoxia in human brain tumors using needle electrodes and EF5 binding. Cancer Res 64: 1886-1892, 2004.
37. 2 histography. Br J Cancer 66: 919-924, 1992.
38. Fleckenstein W, Jungblut JR, Suckfüll M, Hoppe W, and Weiss C. Sauerstoffdruckverteilungen in Zentrum und Peripherie maligner Kopf-Hals-Tumoren. Dtsch Z Mund Kiefer GesichtsChir 12: 205-211, 1988.
39. Füller J, Feldmann HJ, Molls M, and Sack H. Untersuchungen zum Sauerstoffpartialdruck im Tumorgewebe unter Radio- und Thermoradiotherapie. Strahlenther Onkol 170: 453-460, 1994.
40. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, and Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687, 2002.
41. Fyles A, Milosevic M, Wong R, Kavanagh MC, Pintilie M, Sun A, Chapman W, Levin W, Manchul L, Keane T, and Hill RP. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48: 149-156, 1998.
42. Gallez B, Baudelet C, and Jordan BF. Assessment of tumor oxygenation by electron paramagnetic resonance: Principle and applications. NMR Biomed 17: 240-262, 2004.
43. Gatenby RA, Coia LR, Richter MP, Katz H, Moldofsky PJ, Engstrom P, Brown DQ, Brookland R, and Broder GJ. Oxygen tension in human tumors: In vivo mapping using CT-guided probes. Radiology 156: 211-214, 1985.
44. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, and Broder GJ. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14: 831-838, 1988.
45. 2 measurements of intra-abdominal adenocarcinoma in connection with intraoperative radiotherapy before and after change of oxygen concentration of anaesthetic gases. Acta Oncol 40: 105-107, 2001.
46. Grischke EM, Kaufmann M, Eberlein-Gonska M, Mattfeld T, Sohn CH, and Bastert G. Angiogenesis as a diagnostic factor in primary breast cancer: Microvessel quantitation by stereological methods and correlation with color Doppler sonography. Onkologie 17:35-42, 1994.
47. Hänsgen G, Krause U, Becker A, Stadler P, Lautenschläger C, Wohlrab W, Rath FW, Molls, M, and Dunst J. Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys 50: 865-872, 2001.
48. th ed., New York: McGraw-Hill, 2005, pp. 289-321.
49. Höckel M and Vaupel P. Oxygenation of cervix cancers: Impact of clinical and pathological parameters. Adv Exp Med Biol 510: 31-35, 2003.
50. Höckel M and Vaupel P. Prognostic significance of tissue hypoxia in cervical cancer. CME J Gynecol Oncol 6: 216-225, 2001.
51. Höckel M and Vaupel P. Tumor hypoxia: Definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 93: 266-276, 2001.
52. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50, 1993.
53. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, and Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515, 1996.
54. Höckel M, Schlenger K, Höckel S, and Vaupel P. Association between tumor hypoxia and malignant progression: The clinical evidence in cancer of the uterine cervix. In: Tumor Hypoxia, edited by Vaupel P and Kelleher DK. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999, pp. 65-74.
55. Höckel M, Schlenger K, Höckel S, and Vaupel P. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59: 4525-4528, 1999.
56. Höckel M, Schlenger K, Höckel S, Aral B, Schäffer U, and Vaupel P. Tumor hypoxia in pelvic recurrences of cervical cancer. Int J Cancer 79: 365-369, 1998.
57. 2 tension measurements. Cancer Res 51: 6098-6102, 1991.
58. Höckel M, Schlenger K, Mitze M, Schäffer U, and Vaupel P. Hypoxia and radiation response in human tumors. Semin Radiat Oncol 6: 3-9, 1996.
59. Höckel M, Vorndran B, Schlenger K, Baussmann E, and Knapstein PG. Tumor oxygenation: A new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol Oncol 51: 141-149, 1993.
60. Hohenberger P, Felgner C, Haensch W, and Schlag PM. Tumor oxygenation correlates with molecular growth determinants in breast cancer. Breast Cancer Res Treat 48: 97-106, 1998.
61. Jones EL, Prosnitz LR, Dewhirst MW, Marcom PK, Hardenbergh PH, Marks LB, Brizel DM, and Vujaskovic Z. Thermoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 10: 4287-4293, 2004.
62. Kallinowski F and Buhr HJ. Can the oxygenation status of rectal carcinomas be improved by hypoxia? In: Tumor Oxygenation, edited by Vaupel P, Kelleher DK, and Günderoth M. Stuttgart, Jena, New York: Fischer, 1995, pp. 291-296.
63. Kallinowski F, and Buhr HJ. Tissue oxygenation of primary, metastatic and xenografted rectal cancers. In: Tumor Oxygenation, edited by Vaupel P, Kelleher DK, and Günderoth M. Stuttgart, Jena, New York: Fischer, 1995, pp. 205-209.
64. 2-histography. Int J Radiat Oncol Biol Phys 19: 953-961, 1990.
65. Kayama T, Yoshimoto T, Fujimoto S, and Sakurai Y. Intratumoural oxygen pressure in malignant brain tumour. J Neurosurg 74: 55-59, 1991.
66. Knisely JPS, and Rockwell S. Importance of hypoxia in the biology and treatment of brain tumors. Neuroimag Clin N Am 12: 525-536, 2002.
67. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 53: 99-104, 1999.
68. Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, and Vierra M. Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 48: 919-922, 2000.
69. Lally BE, Rockwell S, Fischer DB, Collingridge DR, Piepmeier JM, and Knisely JP. The interactions of polarographic measurements of oxygen tension and histological grade in human glioma and surrounding peritumoral brain tissue. Int J Radiat Oncol 60: S194, 2004.
70. Lartigau E, Randrianarivelo H, Avril M-F, Margulis A, Spatz A, Eschwege F, and Guichard M. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 7: 400-406, 1997.
71. Lartigau E, Haie-Meder C, Cosset MF, Delapierre M, Gerbaulet A, Eschwege F, and Guichard M. Feasibility of measuring oxygen tension in uterine cervix carcinoma. Eur J Cancer 28A: 1354-1357, 1992.
72. Lartigau E, Le Ridant A-M, Lambin P, Weeger P, Martin L, Sigal R, Lusinchi A, Luboinski B, Eschwege F, and Guichard M. Oxygenation of head and neck tumors. Cancer 71: 2319-2325, 1993.
73. Lartigau E, Lusinchi A, Eschwege F, and Guichard M. Tumor oxygenation: The Gustave Roussy experience. In: Tumor Hypoxia, edited by Vaupel P, and Kelleher DK, Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999, pp. 47-52.
74. 2) during accelerated radiotherapy of head and neck carcinoma. Eur J Cancer 34: 856-861, 1998.
75. Lartigau E, Martin L, Lambin P, Haie-Meder C, Gerbaulet A, Eschwege F, and Guichard M. Mesure de la pression partielle en oxygäne dans des tumeurs du col utérin. Bull Cancer/Radiother 79: 199-206, 1992.
76. Lartigau E, Randrianarivelo H, Martin L, Stern S, Thomas CD, Guichard M, Weeger P, Le Ridant A-M, Luboinski B, Nguyen T, Ortoli J-C, Grange F, Avril M-F, Lusinchi A, Wibault P, Haie-Meder C, Gerbaulet A, and Eschwege F. Oxygen tension measurements in human tumors: The Institut Gustave-Roussy Experience. Radiat Oncol Invest 1: 285-291, 1994.
77. 18F-fluoromisonidazole positron emission tomography. BJU international 96: 540-546, 2005.
78. Leo C, Richter C, Horn L-C, Schütz A, Pilch H, and Höckel M. Expression of Apaf-1 in cervical cancer correlates with lymph node metastasis but not with intratumoral hypoxia. Gynecol Oncol 97: 602-606, 2005.
79. Le QT, Chen E, Salim A, Cao Hongbin, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, and Giaccia AJ. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res 12: 1507-1514, 2006.
80. Le QT, Kovacs MS, Dorie MJ, Koong A, Terris DJ, Pinto HA, Goffinet DR, Nowels K, Bloch D, and Brown JM. Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 56: 375-383, 2003.
81. Lyng H, Sundfør K, Tanum G, and Rofstad EK. Oxygen tension in primary tumours of the uterine cervix and lymph node metastases of the head and neck. Adv Exp Med Biol 428: 55-60, 1997.
82. Lyng H, Sundfør K, Trope C, and Rofstad EK. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 6: 1104-1112, 2000.
83. Martin L, Lartigau E, Weeger P, Lambin P, Le Ridant AM, Lusinchi A, Wibault P, Eschwege F, Luboinski B, and Guichard M. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol 27: 123-130, 1993.
84. Mattern J, Kallinowski F, Herfarth C, and Volm M. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 67: 20-23, 1996.
85. Milosevic M, Quirt I, Levin W, Fyles A, Manchul L, and Chapman W. Intratumoral sickling in patient with cervix cancer and sickle trait: Effect on blood flow and oxygenation. Gynecol Oncol 83: 428-431, 2001.
86. Milosevic M, Fyles A, Hedley D, and Hill R. The human tumor microenvironment: Invasive (needle) measurement of oxygen and interstitial fluid pressure. Sem Radiat Oncol 14: 249-258, 2004.
87. Molls M, Feldmann HJ, and Füller J. Oxygenation of locally advanced recurrent rectal cancer soft tissue sarcoma and breast cancer. Adv Exp Med Biol 345: 459-463, 1994.
88. Moringlane JR. Measurement of oxygen partial pressure in brain tumors under stereotactic conditions. Adv Exp Med Biol 345: 471-477, 1994.
89. Movsas B, Chapman JD, Greenberg RE, Hanlon AL, Horwitz EM, Pinover WH, Stobbe C, and Hanks GE. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age. Cancer 89: 2018-2024, 2000.
90. 2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 60: 634-639, 2002.
91. Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, and Hanks GE. Hypoxic regions exist in human prostate carcinoma. Urology 53: 11-18, 1999.
92. Nordsmark M and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57: 39-43, 2000.
93. Nordsmark M and Overgaard J. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43: 396-403, 2004.
94. Nordsmark M, Alsner J, Keller J, Nielsen OS, Jensen OM, Horsman MR, and Overgaard J. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations. Br J Cancer 84: 1070-1075, 2001.
95. Nordsmark M, Bentzen SM, and Overgaard J. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. Acta Oncol 33: 383-389, 1994.
96. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, and Overgaard J. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77: 18-24, 2005.
97. Nordsmark M, Hover M, Keller J, Nielsen OS, Jensen OM, and Overgaard J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int J Radiat Oncol Biol Phys 35: 701-708, 1996.
98. 31P magnetic resonance spectroscopy in human soft tissue tumours. Acta Oncol 36: 565-571, 1997.
99. Nordsmark M, Loncaster J, Aquino-Parsons C, Chou SC, Ladekarl M, Havsteen H, Lindegaard JC, Davidson SE, Varia M, West C, Hunter R, Overgaard J, and Raleigh JA. Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas. Radiother Oncol 67: 35-44, 2003.
100. Nordsmark M, Overgaard M, and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39, 1996.
101. Parker C, Milosevic M, Toi A, Sweet J, Panzarella T, Bristow R, Catton C, Catton P, Crook J, Gospodarowicz M, McLean M, Warde P, and Hill RP. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 58: 750-757, 2004.
102. Pitson G, Fyles A, Milosevic M, Wylie J, Pintilie M, and Hill R. Tumor size and oxygenation are independent predictors of nodal disease in patients with cervix cancer. Int J Radiat Oncol Biol Phys 51: 699-703, 2001.
103. Powell MEB, Collingridge DR, Saunders MI, Hoskin PJ, Hill SA, and Chaplin DJ. Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiother Oncol 50: 167-171, 1999.
104. 2) is not predictive for response to primary systemic chemotherapy (PSC) in operable T2 breast cancer. ASCO-Meeting 2002, Abstract # 1806, 2002.
105. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29: 427-431, 1994.
106. Rofstad EK, Sundfør K, Lyng H, and Trope CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hxpoxia-induced radiation resistance rather than hypoxia induced metastasis. Br J Cancer 83: 354-359, 2000.
107. 2 histography in patients with advanced head and neck cancer. Strahlenther Onkol 177: 462-468, 2001.
108. 2 histography in patients with advanced head and neck cancer. Radiother Oncol 57: 31-37, 2000.
109. 2 histography. Adv Exp Med Biol 345: 451-458, 1994.
110. Saumweber DM, Kau RJ, and Arnold W. Tumor tissue oxygenation in primary squamous cell carcinomas of the head and neck - Preliminary results. In: Tumor Oxygenation, edited by Vaupel P, Kelleher DK, Günderoth M. Stuttgart, Jena, New York: Fischer, 1995, pp. 313-318.
111. Scholbach T, Scholbach J, Krombach GA, Gagel B, Maneschi P, and Di Martino E. New method of dynamic color Doppler signal quantification in metastatic lymph nodes compared to direct polarographic measurements of tissue oxygenation. Int J Cancer 114: 957-962, 2005.
112. Stadler P, Becker A, Feldmann HJ, Hänsgen G, Dunst J, Würschmidt F, and Molls M. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 44: 749-754, 1999.
113. Stadler P, Feldmann HJ, Creighton C, Kau R, and Molls M. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer. Radiother Oncol 48: 157-164, 1998.
114. Stone HB, Brown JM, Phillips TL, and Sutherland RM. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Radiat Res 136: 422-434, 1993.
115. Stone JE, Parker R, Gilks CB, Stanbridge EJ, Liao SY, and Aquino-Parsons. Intratumoral oxygenation of invasive squamous cell carcinoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol 26: 31-35, 2005.
116. Strnad V, Keilholz L, Kirschner M, Meyer M, and Sauer R. Sauerstoffdruckverteilung in Lymphknotenmetastasen und die Veränderungen während akuter respiratorischer Hypoxie. Strahlenther Onkol 173: 267-271, 1997.
117. Sundfør K, Lyng H, and Rofstad EK. Oxygen tension and vascular density in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Acta Oncol 37: 665-670, 1998.
118. Sundfør K, Lyng H, and Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 78: 822-827, 1998.
119. 2 in cervix carcinoma. Gynecol Oncol 64: 230-236, 1997.
120. Sundfør K, Lyng H, Trope CG, and Rofstad EK. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiother Oncol 54: 101-107, 2000.
121. Swartz HM and Dunn J. The difficulties in comparing in vivo oxygen measurements: Turning the problems into virtues. Adv Exp Med Biol 566: 295-301, 2005.
122. Terris DJ. Head and neck cancer: The importance of oxygen. Laryngoscope 110: 697-707, 2000.
123. Vaupel P. Blood flow and metabolic microenvironment of brain tumors. J Neuro-Oncol 22: 261-267, 1994.
124. Vaupel P. Abnormal microvasculature and defective microcirculatory function in solid tumors. In: Vascular-Targeted Therapies in Oncology, edited by Siemann DW. Chichester, UK: Wiley & Sons, 2006, pp. 9-29.
125. Vaupel P. Blood flow, oxygenation, tissue pH distribution and bioenergetic status of tumors. Berlin: Ernst Schering Research Foundation, Lecture 23, 1994.
126. Vaupel P. Durchblutung und Oxygenierungsstatus von Kopf-Hals-Tumoren. In: Klinik des Rezidivtumors im Kopf-Hals-Bereich, edited by Bottcher HD, Wendt TG, and Henke M. München: Zuckschwerdt, 2001, pp. 7-23.
127. Vaupel P. Durchblutung, Sauerstoffversorgung, Glukoseaufnahme und pH-Gradienten in Hirntumoren. In: Klinik der hirneigenen Tumoren und Metastasen - Grundlagen, Diagnostik, Therapie, edited by Bottcher HD, Seifert V, Henke M, and Mose St. München: Zuckschwerdt, 2002, pp. 34-49.
128. Vaupel P. The role of hypoxia-induced factors in tumor progression. Oncologist 9 (Suppl. 5): 10-17, 2004.
129. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14: 198-206, 2004.
130. Vaupel P and Harrison L. Tumor hypoxia: Causative factors, compensatory mechanisms, and cellular response. Oncologist 9 (Suppl. 5): 4-9, 2004.
131. Vaupel P and Höckel M. Blood supply, oxygenation status and metabolic micromilieu of breast cancers: Characterization and therapeutic relevance. Int J Oncol 17:869-879, 2000.
132. Vaupel P and Höckel M. Durchblutung, Oxygenierungsstatus und metabolisches Mikromilieu des Mammakarzinoms. Pathomechanismen, Charakterisierung und biologische/therapeutische Relevanz. In: Diagnostik und Therapie des Mammakarzinoms - State of the Art, edited by Untch M, Sittek H, Bauerfeind I, Reiser M, and Hepp H. München: Zuckschwerdt, 2004, pp. 347-367.
133. Vaupel P and Höckel M. Hypoxie beim Zervixkarzinom: Pathogenese, Charakterisierung und biologische/klinische Konsequenzen. Zentralbl Gynäkol 123: 192-197, 2001.
134. Vaupel P and Höckel M: Oxygenation status of breast cancer: The Mainz experience. In: Tumor Hypoxia, edited by Vaupel P and Kelleher DK. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 1999, pp. 1-11.
135. nd edit, Edinburgh, London: Elsevier, 2005, pp. 47-66.
136. Vaupel P and Mayer A. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet 363: 992, 2004.
137. Vaupel P, Briest S, and Höckel M. Hypoxia in breast cancer: Pathogenesis, characterization and biological/therapeutic implications. Wien Med Wschr 152: 334-342, 2002.
138. Vaupel P, Dunst J, Engert A, Fandrey J, Feyer P, Freund M, and Jelkmann W. Effects of recombinant human erthropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia. Onkologie 28: 216-221, 2005.
139. Vaupel P, Kallinowski F, and Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 49: 6449-6465, 1989.
140. Vaupel P, Mayer A, and Höckel M. Impact of hemoglobin levels on tumor oxygenation: the higher, the better? Strahlenther Onkol 182: 63-71, 2006.
141. Vaupel P, Mayer A, and Höckel M. Oxygenation status of primary and recurrent squamous cell carcinomas of the vulva. Eur J Gynaecol Oncol 27: 142-146, 2006.
142. Vaupel P, Mayer A, Briest S, and Höckel M. Oxygenation gain factor: A novel parameter characterizing the association between hemoglobin level and the oxygenation status of breast cancers. Cancer Res 63: 7634-7637, 2003.
143. 2 tension measurements. Cancer Res 51: 3316-3322, 1991.
144. 2 extraction is a key parameter determining the oxygenation status of malignant tumors and normal tissues. Int J Oncol 22: 795-798, 2003.
145. Vaupel P, Thews O, Mayer A, Höckel S, and Höckel M. Oxygenation status of gynecologic tumors: What is the optimal hemoglobin level? Strahlenther Onkol 178: 727-731, 2002.
146. Vaupel P, Mayer A, and Höckel M. Tumor hypoxia and malignant progression. Methods Enzymol 381: 335-354, 2004.
147. 2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int J Hyperthermia 19: 498-506, 2003.
148. Weitmann HD, Gustorff B, Vaupel P, Knocke TH, and Pötter R. Oxygenation status of cervical carcinomas before and during spinal anesthesia for application of brachytherapy. Strahlenther Onkol 179: 633-640, 2003.
149. Wilson CBJH, Lammertsma AA, McKenzie CG, Sikora K, and Jones T. Measurements of blood flow and exchanging water space in breast tumors using positron emission tomography: A rapid and noninvasive dynamic method. Cancer Res 52: 1592-1597, 1992.
150. Wong RK, Fyles A, Milosevic M, Pintilie M, and Hill RP. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys 39: 405-412, 1997.